Advertisement

Inpharma Weekly

, Volume 1425, Issue 1, pp 5–5 | Cite as

Carboplatin affords superior QOL versus cisplatin in NSCLC

Clinical study
  • 6 Downloads

Keywords

Carboplatin Mitomycin Vinblastine Tumour Response Rate Entire Treatment Period 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2004

Personalised recommendations